Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-042679
Filing Date
2025-04-30
Accepted
2025-04-30 17:20:39
Documents
4
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm252538d1_def14a.htm DEF 14A 266235
2 GRAPHIC tm252538d1_def14aimg001.jpg GRAPHIC 20081
3 GRAPHIC tm252538d1_def14aimg002.jpg GRAPHIC 167279
4 GRAPHIC tm252538d1_def14aimg003.jpg GRAPHIC 70526
  Complete submission text file 0001104659-25-042679.txt   616448
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39202 | Film No.: 25897552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)